Safety and Efficacy Analysis of Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated with SHR-1316 Plus Chemotherapy and Sequential Chest Radiotherapy As First-Line Therapy from a Phase II Trial.
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Tumor Microenvironment,Small-Cell Lung Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined